Key facts
- Puna Bio’s last known valuation is $39.1M (Jun 2025).
- It has raised $20.7M across 1 recorded rounds; the latest was Early Stage VC ($20.3M) in Mar 2025.
- Notable investors include SOSV, IndieBio, Gates Foundation, Builders VC, SVG Ventures|THRIVE — 14 tracked in total.
- Puna Bio has filed 2 Form Ds with the SEC, most recently Jun 2025 ($20.3M sold to 20 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Puna Bio
Funding rounds
1 roundsAbout Puna Bio
Producer of biological products intended to improve farmers' yield in an environmentally suitable way. The company's products help to increase yields and improve crop quality, grow crops on degraded soils and restore and enrich soils for agriculture with sustainable biological products, enabling farmers to increase productivity and production.
- Sector
- Materials and Resources
- HQ
- Buenos Aires, Argentina
- Founded
- 2020
- Employees
- 49
- Website
- puna.bio/
- Ownership
- Privately Held (backing)
Puna Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Puna Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Puna Bio in its N-PORT filings yet. We sweep new filings monthly.